Titre:
  • Survival among patients with relapsed/refractory diffuse large B cell lymphoma treated with single-agent selinexor in the SADAL study
Auteur:Maerevoet, Marie; Zijlstra, Josée J.M.; Follows, George; Casasnovas, René Olivier; Vermaat, Joost J.S.P.; Kalakonda, Nagesh; Goy, Andre; Choquet, Sylvain; Van Den Neste, Eric; Hill, Brian; Thieblemont, Catherine; Cavallo, Federica; De la Cruz, Fátima; Kuruvilla, John; Hamad, Nada; Jaeger, Ulrich; Caimi, Paolo; Gurion, Ronit; Warzocha, Krzysztof; Bakhshi, Sameer; Sancho, Juan Manuel; Schuster, Michael; Egyed, Miklos; Offner, Fritz; Vassilakopoulos, Theodoros; Samal, Priyanka; Ku, Matthew; Ma, Xiwen; Corona, Kelly; Chamoun, Kamal; Shah, Jatin; Shacham, Sharon; Kauffman, Michael; Canales, Miguel
Informations sur la publication:Journal of Hematology & Oncology, 14, 1, 111
Statut de publication:Publié, 2021-12
Sujet CREF:Généralités
Mots-clés:DLBCL
Exportin-1
Selinexor
SINE compounds
Note générale:SCOPUS: le.j
Langue:Anglais
Identificateurs:urn:issn:1756-8722
info:doi/10.1186/s13045-021-01122-1
info:scp/85110471440